The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Summarize the effects of antibiotics on gut microbiota, its metabolic byproducts, and intestinal health
Define targeted efforts to maintain gut health and mitigate intestinal pathogenic bacteria colonization induced by antibiotic therapy
Describe whether gut microbiome composition predicts low FODMAP diet efficacy in irritable bowel syndrome (IBS)
Determine whether a low FODMAP diet alters gut microbiome composition and/or metabolite profiles in those with IBS
Identify the role of the fecal microbiome in IBD
Describe how diet changes the fecal microbiome
Speaker(s):
Gail
Cresci,
PhD, RD,
Director, Nutrition Research, Center for Human Nutrition, Digestive Disease & Surgery Institute,
Cleveland Clinic, Cleveland, OH
Bruno
Chumpitazi,
PhD,
Associate Professor, Baylor College of Medicine; Director, Neurogastroenterology and Motility Program,
Texas Children's Hospital, Houston, TX
David
Suskind,
MD,
Director of Clinical Gastroenterology, Seattle Children's Hospital; Professor of Pediatrics,
University of Washington School of Medicine, Seattle, WA